Bibliography
Export 26 results:
Filters: Keyword is Survival Rate [Clear All Filters]
Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association// Nephrol Dial Transplant. 2012;27(7):2971-9.
Kidney damage during organ recovery in donation after circulatory death donors: data from UK National Transplant Database. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons// Am J Transplant. 2012;12(4):932-6.
Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons//Am J Transplant. 2011;11(12):2708-14.
Infections in heart transplant recipients in Brazil: the challenge of Chagas' disease. J Heart Lung Transplant. 2010;29(3):286-90.
Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe? Transplantation. 2009;87(8):1180-90.
Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience. Transpl Infect Dis. 2008;10(5):316-24.
Intrathoracic organ transplantation from donors with meningitis: a single-center 20-year experience. Ann Thorac Surg. 2008;86(5):1554-6.
Neurologic complications in adult living donor liver transplant recipients. Clin Transplant. 2007;21(4):544-7.
Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34(5):1780-1.
Incidental diagnosis of gastric cancer in transplant recipients improves patient survival. Surgery. 2002;132(4):754-8; - discussion - 758-60.
De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl. 2001;7(1):1.
Effect of ABO blood type matching in cardiac transplant recipients. Transplant Proc. 2001;33(5):2752-4.
Long-term complications of living donor liver transplantation. Liver Transpl. 2000;6(6 Suppl 2):S73-6.
The use of contaminated donor organs in transplantation. Clin Transplant. 2000;14(4 Pt 2):397-400.
An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified? Clin Transplant. 1999;13(6):531-5.
Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis. 1999;29(3):561-7.
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. Transplant Proc. 1999;31(7A):84S-85S.
Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report. Jama. 1998;280(13):1153-60.
De novo malignances in pediatric organ transplant recipients. Pediatr Transplant. 1998;2(1):56-63.
Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1998:147-58.
Comparison of cadaveric and living liver donors. Transplant Proc. 1997;29(8):3408-9.
United Network for Organ Sharing Donor Data Update, 1988-1995. Transplant Proc. 1997;29(40575):122-4.
Malignancy. Surg Clin North Am. 1994;74(5):1247-57.
HIV transmission by organ and tissue transplantation. AIDS. 1993;7 Suppl 2:S35-8.
JOURtrolyte and acid-base changes with massive blood transfusions. The American surgeon//Am Surg. 1992;58(9):535.